February 2016 - Dr. Rath Research Institute

Globally, resistance to treatment with antimicrobial drugs is becoming an increasingly serious public health problem. Antimicrobial resistance is a larger phenomenon than antibiotic resistance. In addition to drug resistant bacteria, the antimicrobial resistant species also include other drug resistant microbes such as fungi, parasites, and viruses. According to the World Health Organization (WHO), 480,000 new cases of multi drug resistant tuberculosis (XDR-TB) were diagnosed in 2013. Other disease causing and highly virulent organisms that have already developed drug resistance are malarial parasites, the fungus Candida, methicillin-resistant-Staphylococcus aureus (MRSA), and the bacteria causing gonorrhea. The drug resistant bacteria are estimated to cause 99,000 deaths in U.S. hospitals every year.

After heart disease, cancer is the second leading cause of death worldwide. One in two men and one in three women will be diagnosed with some type of cancer in their lifetime. Despite novel initiatives, the American Cancer Society estimates that by 2020 the number of new cancers will increase to more than one million cases per year in men, and more than 900,000 cases per year in women. Melanoma, lung, breast, and prostate cancer are the most commonly diagnosed among the new cancers. Although cigarette smoking - the most common risk factor for cancer - still remains high, obesity and other metabolic disorders can contribute to and increase breast, colon, uterus, pancreas, and kidney cancers.